Cornea Biosciences was founded in 2011 with the express objective of furthering development of the bioengineered cornea, and providing this cornea to the millions of people unilaterally or bilaterally blind from corneal disease or injury and unable to obtain a corneal transplant due to a severe shortage of human donor corneas. The company’s cornea is the result of ten years of research and development conducted at the University of Ottawa in Canada and Linkoping University in Sweden.